Vectura News Discover more about our company, science, innovation and people with the latest headlines from Vectura.
Vectura Expands Dry Powder Inhaler Development and Manufacturing Capabilities at its Facility in Chippenham, U.K. Published05/03/2021 Read more
Vectura Group appoints Jeanne Hecht and Jeanne Thoma to its Board of Directors Published30/12/2020 Read more
Vectura earns $11m milestone as Hikma receives US FDA approval for generic Advair Diskus® Published17/12/2020 Read more
Vectura Expands Capabilities to Handle and Develop Highly Potent Inhaled Drugs at its Facility in Chippenham, U.K. Published14/12/2020 Read more
Vectura signs agreement with Kinaset Therapeutics Inc. to support the development of VR588 to treat asthma Published30/11/2020 Read more
Will Downie’s podcast: “There’s a patient at the end of every piece of work we do…” Published08/10/2020 Read more
Vectura shortlisted for ’Excellence in Pharma: Contract Services and Outsourcing’ Published24/09/2020 Read more
